Unisom Pregnancy Birth Defects in the US 2025 The relationship between Unisom (doxylamine succinate) use during pregnancy and potential birth defects has been extensively studied and monitored by US health…

Phocomelia Disease in the US 2025 Phocomelia disease represents one of the rarest and most severe congenital limb defects affecting newborns in the United States in 2025. This devastating condition,…

Neural Tube Defects in the US 2025 Neural tube defects continue to represent one of the most significant preventable birth defects affecting American families in 2025. These severe congenital abnormalities…

Heart Defects in the US 2025 Congenital heart defects represent the most common category of birth defects affecting newborns across the United States in 2025, with comprehensive surveillance data revealing…

Birth Disease in the US 2025 The landscape of birth Disease in the United States continues to present significant challenges for families, healthcare providers, and public health officials in 2025.…

Paracetamol in the US 2025 Paracetamol, known as acetaminophen in the United States, remains one of America's most widely used over-the-counter pain relievers and fever reducers. With over 60 million…

Introduction Recent policy announcements and scientific publications have renewed attention on the potential association between acetaminophen (also known as paracetamol or by brand names like Tylenol) use during pregnancy and…

Mpox in the United States 2025 The mpox landscape in the United States has evolved significantly throughout 2025, with health authorities maintaining vigilant surveillance across both clade I and clade…

Bipolar Depression in the US 2025 Bipolar depression represents one of the most complex and challenging mental health conditions affecting Americans today, characterized by dramatic shifts between manic and depressive…